127 related articles for article (PubMed ID: 6147253)
1. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
Reiz S; Friedman A; Häggmark S
Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
6. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
7. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
[No Abstract] [Full Text] [Related]
9. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
11. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
14. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
15. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
Dahlström U; Karlsson E; Wranne B
Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
[No Abstract] [Full Text] [Related]
18. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
Tydén H; Johansson L; Nyström SO
Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
20. Echocardiographic comparison between prenalterol and dobutamine.
Wester HA; Oltmanns D
Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
